Similar articles

• Immunoaffinity purification and quantification of antibody-toxin conjugates.

  Wawrzynczak EJ, Cumber AJ. Wawrzynczak EJ, et al. Methods Mol Biol. 1998;80:145-53. doi: 10.1385/0-89603-493-3:145. Methods Mol Biol. 1998. PMID: 9664371 No abstract available.
• Selective cytotoxic effects of immunotoxin--monoclonal anti-AFP-abrin-A chain conjugate on several human hepatoma cell lines.

  Chow LP, Chang KH, Lin JY. Chow LP, et al. Biochem Int. 1990 Oct;22(1):95-102. Biochem Int. 1990. PMID: 1704234
• Purification of immunotoxins containing ricin A-chain and abrin A-chain using blue sepharose CL-6B.

  Knowles PP, Thorpe PE. Knowles PP, et al. Anal Biochem. 1987 Feb 1;160(2):440-3. doi: 10.1016/0003-2697(87)90073-x. Anal Biochem. 1987. PMID: 3495199
• Antibody-toxin conjugates: a new approach to cancer therapy.

  McIntosh DP. McIntosh DP. Adv Biotechnol Processes. 1984;3:111-39. Adv Biotechnol Processes. 1984. PMID: 6399840 Review. No abstract available.
• Effect of chemical linkage upon the stability and cytotoxic activity of A chain immunotoxins.

  Wawrzynczak EJ, Thorpe PE. Wawrzynczak EJ, et al. Cancer Treat Res. 1988;37:239-51. doi: 10.1007/978-1-4613-1083-9_14. Cancer Treat Res. 1988. PMID: 2908627 Review. No abstract available.